Overview

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Status:
Completed
Trial end date:
2020-03-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if abatacept is effective in the treatment of early rheumatoid arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Abatacept
Methotrexate